Clinical Trial Update: Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 trial assessed the effects of the carbidopa/levodopa/entacapone combination on motor function and quality of life in Parkinson's disease patients experi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Stalevo (levodopa;carbidopa;entacapone)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Parkinson's Disease With End of Dose Wearing Off | Phase 4 | Status: COMPLETED | Results posted: 2011-03-15